Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Depression
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Depression
    Duloxetine, SSRIs Produce Similar Rates of Sexual Dysfunction in Patients With Depression: Presented at WCBP - (DGDispatch)
    TopAbstracts in Depression 07/01/2009 - (DGNews)
    Desvenlafaxine Reduces Anxiety Associated With Major Depressive Disorder: Presented at WCBP - (DGDispatch)
    Desvenlafaxine Is Effective for Major Depressive Disorder: Presented at WCBP - (DGDispatch)
    Armodafinil Improves Excessive Sleepiness Associated With Treated Obstructive Sleep Apnoea in Patients With Depression: Presented at ENS - (DGDispatch)

    News archive

     Recent webcasts/CME - Depression
      Treatment-Resistant Depression -- Part III: Switching Antidepressants vs. Conventional Augmentation Strategies
      On the Front Line of Major Depressive Disorder and Comorbidities: Managed Care and the Primary Care Physician
      Treatment-Resistant Depression -- Part II: Augmentation Strategies
      Treatment-Resistant Depression -- Part I: Introduction and Clinical Presentations
      Enhancing Treatment for Patients with Comorbid Depression, Diabetes and Heart Disease

      Webcasts/CME archive

       Recent cases - Depression
        Creutzfeldt-Jacob Disease Presenting as Severe Depression: A Case Report
        Sexual Dysfunction in a Young Mother
        Psychiatric Disorder Associated with Vacuum-Assisted Breast Biopsy Clip Placement: A Case Report
        A Postmenopausal Woman Presenting with Ekbom Syndrome Associated with Recurrent Depressive Disorder: A Case Report
        Affective Psychosis, Hashimoto's Thyroiditis, and Brain Perfusion Abnormalities: Case Report

        Cases archive
          




        my personal edition > depression > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Higher Effect On Cardiac Autonomic Function With Nortriptyline Than Paroxetine

        A DGReview of :"Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures"
        Biological Psychiatry

        10/23/2002
        By Harvey McConnell


        Nortriptyline has stronger vagolytic effects on cardiac autonomic function compared with paroxetine, clinicians have found in a study among patients with major depression and ischemic heart disease.

        Paroxetine may have some cardioprotective effects, especially in cardiac patients, suggest researchers at the departments of psychiatry at Wayne State University School of Medicine, Detroit, Michigan, and Columbia University School of Medicine, New York, New York, United States.

        The clinicians point out that earlier studies have linked depression to sudden death and serious cardiovascular events in patients with pre-existing cardiac illness. More recent studies have found decreased vagal function in cardiac patients with depression and depressed patients who do not have any cardiac illness.

        In the current study, the clinicians assessed the 20-hour sleeping and awake heart period variability measures using spectral analysis, fractal dimension, and symbolic dynamics. They compared two groups of patients, with a mean age between 59 and 60, who had major depression and ischaemic heart disease.

        The patients were assessed both before and after they had a six week course of either paroxetine or nortriptyline treatment.

        Spectral measures showed among those who received nortriptyline decreases in awake and sleeping total power, ultra low frequency power, very low frequency power, and low-frequency power. There was a decrease in high-frequency power for the awake condition in patients who received nortriptyline.

        At the same time, a measure of nonlinear complexity, WC-100, significantly increased after among patients receiving paroxetine during the time they were awake.

        Clinicians say their findings suggesting that nortriptyline has stronger vagolytic effects on cardiac autonomic function compared to paroxetine, are in line with previous pre-clinical and clinical reports.
        Biological Psychiatry; Volume 52, Issue 5, pp 418-429. "Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send